Recent Updates
Recently added Catalysts
EOLS Positive Sentiment

Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference

Key Takeaway: Evolus, Inc. will participate in the Needham 25th Annual Virtual Healthcare Conference, featuring a fireside chat and investor meetings. The chat is scheduled for April 14, 2026, at 3:45 PM ET, and will be accessible via their Investor Relations page. A replay will be available for 90 days post-event.
Price reaction · baseline $3.94 (2026-03-30 close) · hit after-hours · clean, no other EOLS news in the window
day 0 close · peak
+4.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Evolus is actively engaging with investors at a prominent healthcare conference.
  • The company is positioned as a leader in the aesthetic injectable market.
  • Evolus showcases its innovative products and customer-centric approach.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~37 mo
Minimal dilution risk
Lead asset
PrabotulinumtoxinA-Xvfs
Phase 2 · Glabellar Frown Lines

Full Press Release Details

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Needham Virtual Healthcare Conference.
The fireside chat will take place on Tuesday, April 14, 2026, at 3:45 PM ET.
The fireside chat can be accessed on the Investor Relations page of the Evolus websitehere. A replay of the webcast will be available 90 days after the date of the presentation.

About Evolus, Inc.

Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau®(prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us atwww.evolus.com, and follow us onLinkedIn,X,InstagramorFacebook.
Jeuveau®and Nuceiva®, are registered trademarks and Evolysse™is a trademark of Evolus, Inc.

Frequently Asked Questions

When is Evolus' fireside chat at the Needham Conference?

The fireside chat is scheduled for April 14, 2026, at 3:45 PM ET.

How can I access the fireside chat?

The chat can be accessed on the Investor Relations page of the Evolus website.

What products does Evolus focus on?

Evolus focuses on aesthetic injectables, including Jeuveau® and Evolysse™.

Will there be a replay of the fireside chat?

Yes, a replay will be available for 90 days after the presentation.

Last updated: Mar 31, 2026